INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Omeros Corporation - OMER

Impact · against what's priced in

The news is largely priced in for Erasca and represents a new legal overhang for Omeros and Concentrix. While Erasca already accounts for a class action lawsuit, Omeros faces a fresh investigation following its EMA setbacks.

ERAS−0.05

Already priced in

The price assumes

A class action lawsuit alleging Erasca misled investors regarding the safety profile and competitive advantage of ERAS-0015